Benfluorex and unexplained valvular heart disease: a case-control study.
<h4>Background</h4>Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is associated with cardiac valve regurgitation.<h4>Methods</h4>We conducted a case-control study. Eligible patien...
Main Authors: | Irène Frachon, Yves Etienne, Yannick Jobic, Grégoire Le Gal, Marc Humbert, Christophe Leroyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-04-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20405030/pdf/?tool=EBI |
Similar Items
-
Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?
by: Florent Le Ven, et al.
Published: (2016-01-01) -
Benfluorex and Mortality: A Fresh Perspective
by: Harvey, N, et al.
Published: (2013) -
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus.
by: Geneviève Derumeaux, et al.
Published: (2012-01-01) -
Sub-aortic obstruction of left ventricular outflow tract secondary to benfluorex-induced endocardial fibrosis
by: Catherine Szymanski, et al.
Published: (2015-12-01) -
Investigations in valvular heart disease.
by: D'Arcy, J, et al.
Published: (2010)